US EditionMEI Pharma’s Crypto Treasury Move: 930,000 Litecoin Tokens Acquired – Crypto News Bitcoin News
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.9 Articles
9 Articles
LATEST: MEI Pharma Begins $100M Institutional Strategy After Acquiring Litecoin Holdings
MEI Pharma (NASDAQ: MEIP) has made history by acquiring 929,548 Litecoin (LTC) tokens at an average price of $107.58, launching a bold institutional treasury strategy now valued at approximately $110.4 million as of August 4, 2025. This move establishes MEI as the first publicly listed U.S. company to designate Litecoin as a primary reserve asset, signaling a new era of digital finance integration within corporate America. Working closely with G…
Large-cap alts: LTC gains 12%, XRP at key level, SOL lands double institutional buy - Invest In Crypto News
Litecoin leads today’s gainers with a 13% jump, renewing interest in large-cap alts. XRP bulls should defend $3.0 to prevent significant dips. Two firms have purchased Solana worth over $23 million. Digital tokens recorded minor price actions on Tuesday as the global cryptocurrency market cap soared 0.15% the past day to $3.73 trillion. Meanwhile, Litecoin led the gainers with an over 12% gain, sparking interest in large-cap and legacy altcoins.…
MEI Pharma’s Crypto Treasury Move: 930,000 Litecoin Tokens Acquired – Crypto News Bitcoin News
MEI Pharma Inc. has become the first U.S.-listed public company to adopt litecoin ( LTC) as a primary reserve asset, deploying $100 million from a recent stock sale to acquire 929,548 tokens of the cryptocurrency. Litecoin Creator Charlie Lee Joins MEI Pharma’s Board The clinical-stage biopharmaceutical company (Nasdaq: MEIP) disclosed the LTC acquisition in an […]
MEI Pharma became the first public company in the United States to adopt Litecoin as a treasury reserve asset. Its purchase boosted LTC’s price by more than 3% to USD 122. *** MEI Pharma purchased more than LTC 900,000 for its corporate portfolio, boosting prices. It is the first public company in the United States to build a treasury strategy focused on Litecoin. LTC’s price skyrocketed at maximums in February over USD 127. The hopes of approva…
Key points of the news: MEI Pharma purchased 929,548 Litecoin units for $100 million, becoming the first company listed in the US to adopt LTC. The operation was financed by a private placement led by Charlie Lee and GSR; Lee joined the board of directors and GSR took over the management of the assets. The company chose Litecoin for its technical stability, low commissions and adoption on platforms such as PayPal and Robinhood. MEI Pharma, a pha…
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
